Form 4: Nuvalent CLO Exercises Options, Sells Shares

Nuvalent's Chief Legal Officer, Deborah Ann Miller, exercised stock options and subsequently sold an equivalent number of shares under a pre-arranged trading plan.

Summary

• Deborah Ann Miller, Nuvalent, Inc.'s Chief Legal Officer, engaged in transactions involving Class A Common Stock on October 30, 2025.
• Miller exercised options to acquire 21,800 shares of Class A Common Stock at an exercise price of $6.89 per share.
• Concurrently, Miller sold a total of 21,800 shares of Class A Common Stock in multiple transactions.
• The sale prices ranged from a weighted average of $96.65 to $104.78 per share.
• All transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2024.
• Following these transactions, Miller directly owns 49,086 shares of Class A Common Stock.
• Miller also directly holds 118,808 derivative securities (stock options) with an exercise price of $6.89, which are fully vested and expire on April 29, 2031.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction under a pre-arranged plan, which is generally neutral in sentiment. While the officer realized gains, the sale of shares is a common practice for liquidity or diversification and does not inherently signal positive or negative company performance.

Positives

• The reporting person realized significant financial gains from exercising options at a low price ($6.89) and selling shares at substantially higher market prices (ranging from $96.65 to $104.78).
• The transactions were conducted under a pre-established Rule 10b5-1 trading plan, indicating a planned, rather than reactive, sale.

Negatives

• The Chief Legal Officer's direct beneficial ownership of Class A Common Stock decreased by 21,800 shares as a result of these transactions.

Risks

• No specific company-wide risks were disclosed in this Form 4 filing, as it primarily reports insider trading activity.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding Nuvalent, Inc.'s future performance or strategic direction.

Industry Context

This filing reports a routine insider transaction (exercise and sale of shares) by a corporate officer, which is common across all industries, particularly in companies where equity compensation is a significant part of executive remuneration. It does not provide specific insights into broader industry trends or competitive landscape.

Corporate Governance

Stakeholder Impact

• **Reporting Person (Deborah Ann Miller):** Realized significant personal financial gains from the option exercise and sale.
• **Shareholders:** The transaction represents a minor increase in the public float due to option exercise, followed by a sale. Given the volume, the impact on overall share price or ownership structure is likely negligible.

Key Dates

Keywords

Nuvalent, NUVL, Insider Trading, Form 4, Stock Options, Share Sale, Chief Legal Officer, 10b5-1 Plan, Equity Compensation